ArticleTranslational andrology and urology2026
Clinical application of compound tung leaf burn oil dressing in postoperative care following circumcision: evaluation of healing time and patient outcomes.
Article in Translational andrology and urology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Circumcision is among the most frequently performed urological procedures worldwide, yet postoperative wound management remains challenging, with complications including pain, edema, and infection affecting patient recovery. Traditional povidone-iodine (PVP-I) gauze dressings have limitations in promoting optimal wound healing. Compound tung leaf burn oil (CTLBO), a traditional Chinese medicine preparation with anti-inflammatory and wound-healing properties, may offer advantages in postoperative circumcision care. This study aimed to evaluate the clinical efficacy and safety of CTLBO-containing dressings compared with conventional PVP-I gauze in postoperative care following circumcision. Methods: This retrospective cohort study analyzed 132 adult male patients (aged 18-50 years) who underwent elective circumcision at Ganzhou People's Hospital between January 2022 and December 2024. Patients with coagulation disorders, uncontrolled diabetes [glycated hemoglobin (HbA1c) >8%], immunocompromised status, or incomplete follow-up were excluded. Patients were divided into the CTLBO group (n=68) receiving CTLBO dressing and the control group (n=64) receiving conventional PVP-I gauze based on clinical practice patterns. Standardized dressing protocols were employed with changes every 24-48 hours during the first postoperative week. Primary outcomes included visual analogue scale (VAS) pain scores, wound infection rate, edema scores, wound healing time, complication rates, and patient satisfaction, assessed at postoperative days 1, 3, and 7, and at complete healing. Results: The CTLBO group demonstrated significantly lower VAS pain scores at postoperative day 1 (4.37±0.50 Conclusions: CTLBO dressing demonstrates superior efficacy in reducing postoperative pain, edema, infection, and healing time following circumcision compared with conventional PVP-I gauze. These findings support CTLBO as an effective alternative for postoperative wound management in circumcision patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.